Cargando…
Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer
Serine and arginine rich splicing factor 2(SRSF2) belongs to the serine/arginine (SR)-rich family of proteins that regulate alternative splicing. Previous studies suggested that SRSF2 can contribute to carcinogenic processes. Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidn...
Autores principales: | Kędzierska, Hanna, Popławski, Piotr, Hoser, Grażyna, Rybicka, Beata, Rodzik, Katarzyna, Sokół, Elżbieta, Bogusławska, Joanna, Tański, Zbigniew, Fogtman, Anna, Koblowska, Marta, Piekiełko-Witkowska, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085631/ https://www.ncbi.nlm.nih.gov/pubmed/27690003 http://dx.doi.org/10.3390/ijms17101598 |
Ejemplares similares
-
Correction: Kędzierska, H., et al. Decreased Expression of SRSF2 Splicing Factor Inhibits Apoptotic Pathways in Renal Cancer. Int. J. Mol. Sci. 2016, 17, 1598
por: Kędzierska, Hanna, et al.
Publicado: (2020) -
MicroRNA-Mediated Metabolic Reprograming in Renal Cancer
por: Bogusławska, Joanna, et al.
Publicado: (2019) -
Disturbed Expression of Splicing Factors in Renal Cancer Affects Alternative Splicing of Apoptosis Regulators, Oncogenes, and Tumor Suppressors
por: Piekielko-Witkowska, Agnieszka, et al.
Publicado: (2010) -
Epigenetic Regulation of Thyroid Hormone Receptor Beta in Renal Cancer
por: Wojcicka, Anna, et al.
Publicado: (2014) -
TGF-β1 affects the renal cancer miRNome and regulates tumor cells proliferation
por: Hanusek, Karolina, et al.
Publicado: (2022)